 |
Bernard Lemoine: strategic vision, concrete results
Thursday 20 November 2008
James Mills - Deputy Editor
After 20 years as director-general of France's pharmaceutical industry association, Leem, Bernard Lemoine will step down at the end of January. And then he plans to start work.
He wants Europe to become more attractive as an investment destination for international pharmaceutical companies, he wants public and private researchers to work together more closely, and he wants to be there when thriving mid-sized biotechnology companies begin to emerge from Europe's life sciences sector...
Login to view the full article
- Not a subscriber? Request a FREE trial
- Subscribe to Scrip
- Email to a friend
Comments
No Comments Yet
About Scrip
Scrip World Pharmaceutical News provides you with high quality news coverage of pharma and biotech and also gives you strategic data and analysis.
Benefits include:
›› Daily email headlines
›› Searchable news
archive
›› Weekly copies of Scrip
›› Bespoke Scrip supplements
›› Plus the Scrip Yearbook
and Scrip League Tables
Scrip Awards 2008
The best and brightest of the pharmaceutical and biotech industries were celebrated at a glittering ceremony in London at the 2008 Scrip Awards.
Read the full story
Scrip Directory
Scrip Directory 2008
Search over 20,000 international contacts and access potential business opportunities
© Informa plc. All rights reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is
Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
